Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
King
King is currently an MD student at Harvard. He earned his BA in Sociology and Health from University Notre Dame, and earned a MS in Global Public Health and Policy at Queen Mary University of London.
Helena
Helena studied at Columbia and NYU. She has served as a Contributing Editor and Senior Contributor at The New Inquiry, and her work has been excerpted or cited in The Atlantic, Harper's, and The New York Times, among others.